DRADS Capital is a Boston-based venture fund investing in life sciences, biotechnology, and A.I. companies focused on extending the boundaries of biomedical sciences. Our unique approach merges breakthrough science and technology from top academic laboratories and hospitals with strong leadership teams that are transforming how we treat and improve neurological health. Our portfolio of companies are unlocking human potential in treating neurodegenerative disease, improving mind-body wellness, and quantifying brain health.
| Website | https://www.dradscapital.com/ |
| Employees | 8 (3 on RocketReach) |
| Founded | 2018 |
| Technologies |
HTML
,
G Suite
,
Bootstrap
+4 more
(view full list)
|
| Industry | Venture Capital and Private Equity Principals, Biotechnology, Science and Engineering, Life Science, Venture Capital, Financial Services, Lending and Investments |
| Keywords | Venture Capital, Biotech Venture Capital, Life Sciences Investing, Biotechnology Investment, Ai Investing, Biomedical Investment, Artificial Intelligence, Science Investment, Medical Technology, Venture Fund, Healthcare Investing, Machine Learning, Bioinformatics, Private Equity, Pharmaceutical Investing, Deep Learning, Seed Funding, Series A Funding, Data Science |
| Competitors | Morgan Stanley, Goldman Sachs, Fidelity Investments, State Street Global Advisors, BlackRock, The Blackstone Group, Vanguard, TIAA, JPMorgan Chase & Co., Schwab Advisor Services +39 more (view full list) |
Looking for a particular DRADS Capital employee's phone or email?
Rajan Pillay is the Founding Managing Director of DRADS Capital.
3 people are employed at DRADS Capital.